Astounding Cancer Treatment? Nothing to see here...

The Cancer Protocol They Don't Want You to Know: How "Curiosity Deficit Disorder" Keeps Terminal Patients from Life-Saving Treatments

TL;DR

• Stage 4 reversals documented: Dr. William Makis reports multiple stage 4 pancreatic cancer patients declared cancer-free using Ivermectin, Mebendazole, and Fenbendazole—cancers previously considered absolute death sentences
• Synergistic power multiplier: These repurposed drugs enhance chemotherapy and radiation effectiveness while dramatically reducing side effects—patients playing golf the day after chemo instead of being bedridden for three days
• The dosing revolution: Ivermectin at 1mg/kg/day, combined with Fenbendazole or Mebendazole at 1,000mg/day (6 days on, 1 off)—protocols refined through thousands of patient cases since early 2023
• Visible results in 90 days: Cancer markers drop within 3-4 weeks, tumor shrinkage visible on imaging within 2-3 months—verifiable data that conventional oncology can't explain
• The access challenge: TWC Canada (where Makis worked) was shut down by Canadian regulators in March 2024; his current independent website (drmakismd.com) and published protocols (archived at OneDayMD.com) provide direct access, while FLCCC physician network offers supervised implementation alternatives after TWC's Canadian operations were dismantled
• The medical suppression playbook: Oncologists in Canada, UK, and Australia threatened to abandon patients who used these protocols, despite watching tumors vanish—the same institutional capture you've seen before
• Natural immune amplifiers: Turkey Tail mushroom stimulates cytotoxic cells and natural killer cells, while Artemisia Annua (2015 Nobel Prize winner alongside Ivermectin) shows remarkable anti-cancer properties
• The vitamin D gap: Most oncologists never test vitamin D levels despite its crucial role in cancer protection and immune function—another critical oversight in the standard of care
• Prevention is paramount: For those vaccinated or at risk, building anti-cancer terrain through functional testing, mitochondrial optimization, and hormonal balance becomes essential when treatment access remains restricted

Does your oncologist suffer from CDD? Well, there's a condition afflicting many of oncology's current practitioners. In his astonishing, information packed interview with Dr. William Makis, Dr. John Campbell terms it "curiosity deficit disorder"—and it's killing people.

When tumors shrink inexplicably, when stage 4 patients defy their prognoses, when conventional treatments work far better than expected, the afflicted practitioner does something remarkable: they ask no questions...

You've Seen This Movie Before

You've already unplugged from their monetary system.

You self-custody your wealth because you understand that "trust, don't verify" is how they steal your future.

You've spent hours down the Bitcoin rabbit hole, learning about proof of work, understanding why decentralization matters, recognizing institutional capture when you see it.

But here's the uncomfortable question: While you're securing your financial future, who's custodying your health?

What good is stacking sats for decades if your biological stack collapses before you can enjoy the fruits of your labor? If your mitochondria are failing, your hormones are in chaos, and your immune system can't distinguish friend from foe?

This installment goes deep into perhaps the most suppressed medical breakthrough of our generation—one that's saving lives right now, in real time, while the establishment does everything in its power to keep you in the dark.

Sign up for Rabbit Hole Health

by Sleuth Wellness

Subscribe for Free

Email sent! Check your inbox to complete your signup.

No spam. Unsubscribe anytime.

The Doctor Documenting What They Can't Explain

Dr. William Makis is a radiologist and nuclear medicine physician who started documenting an explosion of aggressive cancers that don't behave like anything in the oncology textbooks. These aren't the slow-developing malignancies that take years to progress. These are what he calls "turbo cancers"—appearing suddenly, advancing rapidly, killing with frightening efficiency. Young people. Healthy people. People who followed every rule.

In his recent interview with Dr. John Campbell—the same independent voice we've featured before for surfacing inconvenient truths—Makis revealed something remarkable.

As Makis began writing about these cases on Substack, documenting the potential mechanisms and pathophysiology, something unexpected happened. Patients started implementing the protocols he published and reporting outcomes through his online platforms that defied conventional expectations.

"Dr. Makis, you know I read your articles and I took these on my own," they told him through messages and submissions. "My cancers are shrinking. My oncologist is shocked. My oncologist told me I shouldn't be alive anymore and yet I'm here."

One case, intriguing. Two cases, a curiosity. A dozen cases? A pattern emerging. But story after story kept arriving—stage 4 pancreatic cancer patients declared cancer-free, cholangiocarcinoma patients (a rare bile duct cancer with typically grim outcomes) watching tumors shrink, ovarian cancer responding after multiple failed chemotherapy lines.

Makis realized he'd stumbled onto something seismic.

His role evolved from researcher to medical advisor. Today, as Chief Medical Advisor for The Wellness Company, he reviews cases, develops protocols, and guides a network of physicians implementing these approaches. His "clinic" isn't a physical location—it's a virtual advisory practice operating through published research, physician networks, and educational platforms.

Three repurposed drugs. Ivermectin. Fenbendazole. Mebendazole.

Drugs you're told are "horse paste" and "dog dewormers." Drugs that cost pennies. Drugs with decades of safety data. Drugs that are reversing terminal cancer diagnoses.

In the Campbell interview, Makis explained how this evolved: "I did start a cancer clinic or health coaching program with repurposed drugs where I have clients, cancer clients that come to me, we discuss the research, we look at the research and we talk about repurposed drugs and what repurposed drugs they might use and want to try themselves."

This isn't a medical practice in the traditional sense—it's advisory work through The Wellness Company and his published protocols. People read his research, implement the protocols, and report results. Physicians in TWC's network may review cases and provide oversight. Makis analyzes the outcomes and refines recommendations.

The Biochemistry of Hope

Let's get technical for a moment, because this isn't snake oil—this is peer-reviewed science that oncologists either don't know about or aren't allowed to tell you about.

When Dr. Campbell expressed amazement that these drugs could "sensitize a cell to radio-induced cell death," he wasn't exaggerating. The mechanisms are profound.

Ivermectin, Fenbendazole, and Mebendazole act on multiple anti-cancer pathways simultaneously. They stimulate apoptosis—programmed cell death in cancer cells. As Campbell succinctly put it: "The cell just goes pop and dies."

But it goes deeper. These drugs overcome something that makes conventional oncology throw up its hands in defeat: drug resistance. Cancer cells that have developed resistance to chemotherapy—cells that should be invincible—suddenly become vulnerable again.

"A cancer cell that has developed drug resistance to me is absolutely fascinating," Makis explained. Campbell's response captured what many physicians feel: "How can you possibly reverse that? That's just... it's biochemistry well beyond my level of understanding."

The pre-clinical research shows these drugs affecting protein expression, altering biochemical pathways, activating pro-apoptotic mechanisms. They don't just attack cancer—they make cancer attackable by everything else.

The Protocol: Proof of Work for Your Biology

Here's what two years of clinical observations—reviewing patient cases through The Wellness Company network, analyzing outcomes from people implementing his published protocols, and advising supervising physicians—has taught Dr. Makis about dosing:

Ivermectin:

• Standard dose: 1mg per kilogram per day (about 60mg for a 60kg/132lb person)
• For low-grade cancers (such as chronic lymphocytic leukemia that's been stable for years, or early-stage multiple myeloma): 0.5mg/kg per day
• Duration: 3-month trial with reassessment
• Results: Cancer markers can drop within 3-4 weeks, tumor shrinkage visible on imaging within 2-3 months
• Seven days per week, no days off

Fenbendazole or Mebendazole:

• Standard dose: 1,000mg per day, split into two doses
• Protocol: 6 days on, 1 day off (to give the liver a break)
• For early-stage or low-grade: 500mg per day
• Duration: Same 3-month assessment window

Mebendazole has one crucial advantage—better penetration through the blood-brain barrier. For any brain tumors or brain metastases, it's the preferred agent. For ovarian cancer, Makis also prefers Mebendazole based on research showing better in-vivo results.

But here's where it gets really interesting.

The Synergy Story: When 1+1=10

A physician assistant in the United States had already completed four cycles of chemotherapy when he started taking Ivermectin. The results were so dramatic they almost sound fictional.

"With my fifth cycle I had no chemo symptoms," he told Makis. "I was playing golf the next day."

Previously, chemotherapy knocked him out for three days. He couldn't function. Now? Playing golf within 24 hours. Every single subsequent cycle was the same.

And his cancer markers? Dropping like a stone.

This synergy isn't anecdotal—it's documented in pre-clinical research. The drugs sensitize cancer cells to chemotherapy and radiation. They don't just work alongside conventional treatment; they amplify its effectiveness while reducing its toxicity.

One radiation oncologist was shocked when tumors shrunk dramatically after just two or three radiation treatments. "Wow, you had an amazing response to just a couple of radiation treatments," they marveled, having no idea that Ivermectin was sensitizing those tumors to radiation.

The patient was too scared to tell them. And that fear? It's not paranoia.

The Institutional Capture Playbook (Again)

If you've been paying attention to Bitcoin, this should be a predictable plot line.

The establishment labels something dangerous. The media amplifies the fear. The regulatory agencies threaten anyone who questions the narrative. The captured institutions enforce compliance through career destruction.

It's the same playbook, different domain.

Dr. Makis reports that patients from Mayo Clinic, Johns Hopkins, Memorial Sloan Kettering, MD Anderson, Dana Farber—the leading cancer centers in America—come to him after being told "there's nothing else we can do for you."

But that's not true. There IS something else. Their oncologists just aren't allowed to tell them.

"Your oncologist probably is not allowed to offer you anything else or to suggest anything else," Makis explains to patients, "because there may be retaliation, their licenses may be targeted, their jobs may be targeted."

Dr. Campbell, with his characteristic directness, responded:

"The oncologists don't have the freedom to go off script... but there's still big ethical questions there. If I know something that might save someone's life and I don't tell them, that's got big ethical questions."

The behavior gets worse outside the United States. In Canada, the UK, and Australia, oncologists routinely threaten patients who attempt these protocols.

"If they do something like this, they'll drop them as a patient," Makis reports. Patients are told they'll be kicked out of trials, abandoned mid-treatment.

Campbell's assessment: "That's bully boy behavior. Bullying."

One patient made the mistake of being honest with their oncologist about taking Ivermectin. The response? Threats and intimidation. "I shouldn't have told my oncologist," the patient told Makis. "I wanted to be honest. I wanted to be open. And now they've threatened me."

So most patients stay silent. Their tumors shrink. Their oncologists marvel at the "amazing response" to standard treatment. The data never gets collected. The pattern stays hidden.

Campbell captured the absurdity:

"Then the data is not being collected really... If this is working, you know, the oncologists are going to be thinking they're a lot cleverer than they actually are."

Exactly. Oncologists attribute exceptional outcomes to their standard protocols, never suspecting that synergistic repurposed drugs are doing the heavy lifting. Their success rates look better. Their confidence in conventional treatment grows. Meanwhile, the actual mechanism driving these remarkable responses remains invisible to institutional medicine.

Meanwhile, doctors who pursue repurposed drugs face systematic professional destruction. Dr. Makis himself hasn't been spared. In 2019, the College of Physicians and Surgeons of Alberta canceled his medical license—not for patient harm, not for malpractice, but for his public statements about vaccine injuries and alternative cancer treatments. He's been declared a vexatious litigant, restricted from filing lawsuits without court permission. He's been found in contempt of court and ordered to pay over $5,600 in costs to Alberta Health Services.

His crime? Speaking publicly about what he observed in his patients. Publishing case studies. Questioning institutional narratives. Advocating for repurposed drugs with better safety profiles than approved chemotherapy agents.

When someone is successfully reversing stage 4 pancreatic cancer—the deadliest diagnosis in oncology—and sharing those protocols publicly, the regulatory response tells you everything. They don't dispute the outcomes. They don't challenge the biochemistry. They attack the messenger's credentials, restrict his ability to defend himself legally, and ensure he can't practice medicine in Canada.

This is what "over the target" looks like. The suppression tactics scale with effectiveness. If his protocols didn't work, he'd be ignored as a harmless crank. Instead, he's systematically dismantled through legal and professional mechanisms.

Other physicians watch and learn the lesson: Stay in line, or lose everything.

Sound familiar?

The Missing Piece: Vitamin D and the Foundation Stack

During the interview, Dr. Campbell asked about vitamin D supplementation. The response reveals another gap in standard oncology.

Makis confirmed vitamin D's crucial role and always asks his patients about their levels. The answer? Universally no—their oncologists never brought it up.

Campbell found this bewildering. Why wouldn't oncologists test for an important immunomodulator? The test isn't complex or expensive—it's basic. Yet they consistently ignore it.

Makis recommends high-dose supplementation—at least 10,000 IU daily if someone is deficient. The same protective effects seen in COVID-19 apply to cancer. Vitamin D deficiency correlates with worse outcomes. Optimal levels appear protective.

But here's what both these doctors miss, and where practitioners who are aware of quantum biology, like myself, focus: Vitamin D isn't just about supplementation. It's about LIGHT exposure.

Vitamin D production is downstream of a far more complex biological process. Your skin, when exposed to proper wavelengths of sunlight, doesn't just produce vitamin D—it produces a cascade of beneficial effects starting with the very function of your mitochondria. Melatonin production in mitochondria. Structured water generation. Circadian rhythm entrainment. Hormonal optimization.

Two pale doctors discussing vitamin D supplementation without mentioning the sun is like discussing Bitcoin without mentioning decentralization. You're missing the fundamental mechanism.

This is where the Sleuth Wellness approach diverges from well-meaning conventional practitioners, and unfortunately, most alternative practitioners too. UV light exposure, circadian biology, electromagnetic environment, breath work, tongue posture—these aren't fringe concepts. They're foundational to mitochondrial function, which is foundational to everything else.

The Natural Medicine Cabinet: Beyond Pharmaceuticals

The conversation took a fascinating turn when Dr. Campbell mentioned turkey tail mushroom.

He told the story of a dog, who had a malignant tumor on his lip. Surgery would have cost £15,000. Instead, the owner tried turkey tail tincture from a local mushroom farm. Within a month, the tumor was gone.

Makis jumped in immediately—turkey tail is something he highly recommends in his protocols. The mechanism? Turkey tail is an immunomodulator that stimulates the immune system to produce more cytotoxic cells—natural killer cells and CD8+ T cells that attack and destroy cancer.

The whole area of medicinal mushrooms holds fascinating potential—turkey tail for immune modulation, lion's mane for neuro-regeneration (Campbell hinted at remarkable stories here), chaga for its bioactive compounds. Another suppressed avenue of natural medicine with profound implications.

Then there's Artemisia Annua.

This plant won the Nobel Prize in 2015—the same year Ivermectin won—for its antimalarial properties. Now it's showing remarkable anti-cancer activity in pre-clinical research.

The bioactive compounds can be taken as the whole plant (tea or supplements) or as isolated extracts like artemisinin and artesunate.

But here's the pattern you'll recognize: When COVID-19 hit, people in various countries started using Artemisia Annua to treat the virus. It worked. So what did the WHO do?

They told people to stop taking it.

The same plant that won a Nobel Prize. The same plant with documented efficacy. Attacked and maligned because it was cheap, accessible, and effective.

Makis observed the pattern: cheap, accessible treatments that people used successfully to treat COVID-19—vitamin D, Artemisia Annua, hydroxychloroquine, Ivermectin, zinc, quercetin—were attacked and maligned by authorities.

Early treatment with readily available substances could have prevented catastrophic outcomes. Instead, these options were suppressed while expensive pharmaceutical interventions were mandated.

If this pattern is becoming predictable, that's because it IS a pattern. The same institutional forces. The same profit motives. The same regulatory capture. Just different therapeutic domains.

The Side Effects That Aren't

One of the most remarkable aspects of these protocols is their safety profile.

With Ivermectin at 1 mg/kg daily, some patients experience transient visual symptoms—seeing colors more vividly, or seeing "stars" as if standing up too quickly. These effects typically last minutes to hours and resolve within one to two weeks as the body adapts.

That's it. That's the extent of common side effects.

"There's reports in the literature of Ivermectin being used at 1 mg/kg for up to a year with no side effects and no long-term effects reported," Makis explained.

With a half-life of 18 hours, if any issues arise, stopping the drug clears it from your system within two days.

For Fenbendazole and Mebendazole, there's a myth about liver toxicity. In the collective experience of over a thousand patient cases reviewed by Makis through his advisory work, elevated liver enzymes occur in less than 3% of cases. When it happens, stopping for a few weeks allows values to normalize, then patients can restart.

Compare this safety profile to standard chemotherapy. Or consider that Ivermectin actually REDUCES chemotherapy side effects, allowing patients to maintain quality of life during treatment.

"Even if it was just for improving the patient's quality of life during chemotherapy, it would be worthwhile," Campbell observed, "because the side effect profile of Ivermectin is so favorable."

The Prostate Cancer Question: When Standard Treatment Isn't the Answer

Many men face a difficult decision when diagnosed with early-stage prostate cancer. Surgery carries risks: incontinence, erectile dysfunction, complications. Radiation therapy brings its own set of potential long-term effects. For some, the cure feels worse than the disease.

In my own family, my father was diagnosed with prostate cancer around 18 years ago. This was before gaining my FDN certification but I urged him to try the Gerson Concord Grape "Cure" I'd found in researching alternatives to chemo, radiation and surgery.

This is a difficult intermittent fasting protocol that involves "starving" the cancer cells from their love for sugar, then bombarding them with antioxidants in the crushed Concord seeds and grapes by consuming only this "mash." As an extremely disciplined ex-marine, he made it almost all the way through the protocol, drastically reducing his PSA numbers.

Granted, this is a very slow moving cancer, but had he been able to make it to the end of the protocol, could he have reversed it. We'll never know. That said, he just celebrated his 90th birthday, is extremely active, and plays pickleball regularly, where the majority of his peers who engaged in traditional therapies for their prostate cancers are, sadly, no longer with us. What, then, could these new, repurposed, safe drugs do for him and the friends he lost along the way?

Makis reports significant interest from men with early-stage prostate cancer seeking alternatives to immediate intervention—ways to potentially shrink tumors or achieve remission without surgery or radiation.

The dosing landscape for prostate cancer reveals fascinating variability. During the Campbell interview, they discussed a case mentioned on Joe Rogan where someone achieved benefit from prostate cancer with just 12 milligrams of Ivermectin daily for several weeks—a remarkably low dose.

Makis confirmed seeing impressive responses at low doses, though he emphasized the wide range of individual variation:

"I could have two prostate cancer patients and one will respond to 12 milligrams of Ivermectin and the other one may not respond to 60 milligrams."

The cancer cell killing is dose-dependent, but optimal dosing varies dramatically from person to person. This is where physician guidance becomes valuable—monitoring PSA (prostate-specific antigen) levels, adjusting doses based on response, combining with Fenbendazole or Mebendazole protocols.

For early-stage prostate cancer, lower starting doses (500mg Fenbendazole daily, 12-30mg Ivermectin daily) with careful monitoring may provide a path that avoids the morbidity of conventional interventions while still addressing the malignancy.

Beyond Cancer: Inflammatory Disease Breakthroughs

The anti-cancer properties of Ivermectin represent just one facet of its therapeutic potential. Makis has documented dramatic responses in chronic inflammatory conditions that have plagued patients for years.

Rheumatoid arthritis patients whose symptoms improve dramatically on Ivermectin at 0.5 mg/kg daily. Fibromyalgia sufferers finding relief within weeks. Lyme disease patients experiencing significant improvement after years of suffering with conventional treatments providing minimal benefit.

The mechanism? Ivermectin appears to have powerful anti-inflammatory properties that extend far beyond its anti-parasitic and anti-cancer effects. For conditions rooted in chronic inflammation—which includes most modern chronic disease—these protocols offer hope where conventional medicine has provided only symptom management.

His body of work—reviewing cases submitted through TWC, analyzing outcomes from people implementing his published protocols, and advising physicians supervising these treatments—now encompasses over a thousand patient experiences across cancer, autoimmune conditions, and inflammatory diseases.

The Research They're Not Funding

Makis emphasized the need for human trials and supported research in this area—regardless of the fact that there's no money to be made. No pharmaceutical company profits. No shareholder returns. Just patient benefit.

There's extensive pre-clinical research on all these compounds. Documented mechanisms. Published studies. Clinical case reports. What's missing is large-scale human trials—the kind that require funding that will never come from pharmaceutical companies with zero profit motive.

But here's the shift happening right now.

Makis believes the suppression that worked for decades is cracking. Information is spreading through X, Substacks, and independent authors. Too many patients having unexplainable responses. Too many documented cases. Too much flowing through decentralized channels the establishment can't control.

With the new administration bringing people focused on scientific freedom rather than regulatory capture, Makis believes we're entering a new era where repurposed drug research could become part of mainstream medicine.

Campbell's somber response: "Just a pity that a lot of people are going to die in pain before we get to that point."

Every day of delay costs lives. Every patient told "there's nothing else we can do" who could have tried these protocols. Every physician threatened into silence who could have helped.

The human cost of institutional capture isn't abstract. It's measured in shortened lives and unnecessary suffering.

Your Health Stack Architecture

Let's talk about what actually works for cancer recovery and prevention, because it's not any single intervention—pharmaceutical or natural.

No supplement protocol, no drug regimen, no matter how promising, works in isolation. Your biology functions as an integrated system where every component affects every other component.

The Sleuth Wellness framework recognizes that cancer—and every chronic disease—represents system-wide failure. Focusing solely on killing malignant cells while ignoring the upstream dysfunction that allowed those cells to thrive is like patching a security vulnerability while leaving the compromised infrastructure intact.

Real recovery requires addressing:

Mitochondrial function - Your cellular power plants must produce energy efficiently. Without this, nothing else works.

Hormonal balance - Steroid hormones don't just affect libido and mood. They regulate cell growth, immune function, inflammation, and cancer surveillance. That's why functional testing like the DUTCH Complete is crucial—it reveals imbalances standard blood panels miss entirely.

Immune function - Your body has sophisticated mechanisms for identifying and destroying malignant cells. When this surveillance system fails, cancer proliferates. Light exposure serves as a critical foundation here—proper UV exposure drives melatonin production in mitochondria, supports circadian biology, and regulates immune function at a fundamental level. Turkey tail mushroom and vitamin D supplementation act as valuable adjuncts, but they support rather than replace the primary systemic work of optimizing light exposure, circadian rhythms, and the upstream factors that govern immune surveillance.

Detoxification capacity - Both environmental toxins and metabolic byproducts must be efficiently eliminated. Overloaded detox pathways create cellular stress that promotes malignancy.

Digestive health - The gut is command center for immune function and inflammation control. Dysfunction here cascades everywhere.

Neurological health - The brain-immune axis, stress response, and autonomic balance profoundly affect cancer progression and recovery.

This is why functional labs aren't optional luxuries—they're essential verification tools. Standard blood work tells you surface-level markers. Functional labs reveal the deeper architecture of your biology.

Perfect carnivore execution with a poor artificial light environment still leaves you deficient in mechanisms that only adherence to circadian biology can resolve.

Perfect keto macros while living in an EMF-saturated environment still damages mitochondrial function. Perfect supplementation while chronically stressed and sleep-deprived still produces suboptimal outcomes.

This is why personalized protocols based on YOUR unique data—not generic advice or one-size-fits-all diets—produce transformative results.

The Practical Reality: How to Actually Access These Protocols

Here's where theory meets the harsh reality of a captured medical system.

You've just read about protocols saving lives. Stage 4 pancreatic cancer reversals. Tumors shrinking. Patients told they had weeks to live now cancer-free. The research exists. The mechanisms are understood. The safety data spans decades.

So how do you actually access this if you or someone you love needs it?

Option 1: Find a Physician to Supervise

Let's start with what "working with Dr. Makis" actually means—and whether direct contact is possible.

When Makis mentioned his "cancer clinic" in the Campbell interview, he was describing a virtual advisory practice rather than a traditional brick-and-mortar clinic. His "clinic" operates through three primary channels:

First, his Substack newsletter (Makis MD) and X/Twitter (@MakisMedicine) where he publishes detailed protocols, analyzes patient case studies, and provides educational guidance. This is his primary vehicle for disseminating information—coaching at scale through published research.

Second, his role as Chief of Nuclear Medicine & Oncology and Chief Medical Advisor for The Wellness Company (TWC). When he references patient cases and outcomes, he's often describing his advisory work through TWC's physician network—physicians he trains and guides who implement his protocols.

Third, direct communication attempts. The landscape here is confusing because Dr. Makis has been in transition following regulatory suppression.

What Changed: In March 2024, The Wellness Company Canada was shut down by regulatory pressure from the Canadian government. As Dr. Paul Alexander reported: "The attacks on TWC were aggressive for the powers at be saw the scope of TWC, its vision, what it was capable of doing and offering, and decided that TWC must be pummelled into withdrawal."

Dr. Makis was part of TWC Canada and lost that platform. TWC USA continues operating, but it's unclear whether they're still implementing Makis's specific high-dose protocols or if that relationship ended with the Canadian shutdown.

This likely explains why Makis established his own website—he needed an independent platform after TWC Canada was dismantled.

Current Contact Options (as of 2025):

Primary - Dr. Makis Direct:

• Website: drmakismd.com (appears to be his current official site, 2025 copyright)
• Email: frontdesk@drmakismd.com (listed on website)
• Alternative email: Info@makisw.com (listed via X as of January 2025)
• Legacy email: Some sources reference makisw79@yahoo.com, though newer channels may supersede this

Social Media:

• X (Twitter): @MakisMedicine (active and monitored)
• Substack: Makis MD newsletter (responds to comments, publishes detailed protocols)

TWC USA (Status Uncertain):

• Website: TWC.health
• Phone: (800) 758-1584
• Email: support@twc.health
• Important caveat: TWC Canada (where Makis worked) was shut down March 2024. While Makis is listed as Chief Medical Advisor on TWC USA's website, it's unclear whether their physicians will implement his high-dose cancer protocols or if this is a legacy listing. Contact them directly to verify if they're still working with Makis's protocols.

Protocol Reference Resource:

• OneDayMD.com maintains comprehensive Makis protocol archives: https://www.onedaymd.com/2024/07/ivermectin-articles-and-protocols-for.html This site aggregates his ivermectin research and dosing guidelines—invaluable if you're implementing independently or need protocol references for supervising physicians.

Recommended Approach:

1. For direct consultation with Dr. Makis: Start with his website contact form (drmakismd.com) or email (frontdesk@drmakismd.com). If no response, try X DMs or the alternative email.
2. For physician-supervised implementation:
   • Contact TWC USA to verify if they still implement Makis protocols (unclear post-Canada shutdown)
   • Otherwise, use FLCCC Provider Directory (covid19criticalcare.com/provider-directory) to find physicians familiar with repurposed drug protocols
   • Or Truth for Health Foundation network (truthforhealth.org)
3. For protocol references: Use OneDayMD.com as your research library while you find supervising physicians (Chrome may deny access so use the expanded link above or search for the main site through Duckduckgo.com or the privacy-based search engine of your choice)

If attempting direct contact with Makis, be concise and specific: cancer type/stage, prior treatments, current status, relevant lab values/imaging dates, specific protocol questions. Show you've read his research. Understand that individual consultation capacity is limited—he may direct you to his published protocols or suggest finding a supervising physician through other networks.

The Reality of Access: The regulatory suppression that shut down TWC Canada—dismantling Makis's primary distribution platform—illustrates exactly what we're up against. When effective protocols threaten established interests, they don't debate the science. They eliminate the infrastructure that makes treatment accessible.

This is why having multiple access pathways matters. Makis's independent website, his published protocols on One Day MD, the FLCCC physician network—distributed systems that can't be shut down with a single regulatory action.

Simultaneous with Bitcoin Historico in El Salvador, Makis will be speaking at the Reclaiming Health and Longevity Symposium:

If Direct Contact with Makis Isn't Feasible (Most Cases):

Beyond attempting to reach Dr. Makis directly, there are established networks of physicians in the United States who understand these protocols and will supervise implementation. They're not in the mainstream system—you won't find them at major cancer centers. They operate in the cash-based, integrative medicine space where doctors have chosen medical freedom over institutional compliance.

Your additional paths to find supervising physicians:

Beyond attempting to reach Dr. Makis directly, you'll need physicians willing to supervise repurposed drug protocols—and the landscape here shifted dramatically in 2024.

The TWC Situation: The Wellness Company Canada, where Makis worked as part of the medical advisory team, was shut down in March 2024 by Canadian regulatory pressure. As Dr. Paul Alexander reported: "The attacks on TWC were aggressive... and decided that TWC must be pummelled into withdrawal."

TWC USA continues operating, and Makis is still listed on their website as Chief Medical Advisor. However, it's unclear whether TWC USA physicians are actively implementing his high-dose cancer protocols following the Canadian shutdown, or if this represents a legacy affiliation. If you contact TWC USA, specifically ask whether they supervise the Makis protocols (1mg/kg Ivermectin, 1000mg Fenbendazole/Mebendazole). Don't assume they do.

More Reliable Physician Networks:

Given the TWC uncertainty, these networks provide clearer pathways to physicians familiar with repurposed drug protocols:

FLCCC Provider Directory: The Front Line COVID-19 Critical Care Alliance maintains a network of physicians who prescribe Ivermectin and other repurposed drugs. Many have expanded from COVID treatment into long COVID, vaccine injury, and cancer protocols using similar approaches. Find them at covid19criticalcare.com/provider-directory.

Truth for Health Foundation: Another network of doctors advocating patient choice and innovative treatment protocols. Visit truthforhealth.org.

Independent Integrative Oncology Clinics: Search "integrative oncology," "metabolic cancer therapy," or "alternative cancer treatment" in your area. These are cash-based practices outside insurance networks.

The reality of "supervision" from these physicians typically looks like this: They review the protocol. They order baseline labs (liver function, kidney function, blood counts) and monitor periodically. They may write prescriptions for human-grade Ivermectin and Mebendazole through compounding pharmacies. They provide guidance on side effects and interactions.

Many won't initiate the high-dose protocol themselves but will agree to monitor you while you implement it. They're providing oversight, not prescription—a crucial legal distinction.

Expect to pay cash. Expect it to be expensive. The system ensures that medical freedom comes with a price tag most can't afford.

Option 2: The Full Self-Sovereign Approach

For those who can't access (or can't afford) physician supervision, there's the DIY path. This is where people source veterinary Ivermectin paste and research-grade Fenbendazole powder, calculate their own doses, and implement protocols independently.

I'm not providing medical advice here—I'm an FDN-P, a functional health detective who works with natural approaches. But people are doing this. Successfully. Here's what that landscape looks like:

Fenbendazole: Available as pure powder from suppliers like FreeRange Supplements and others. The dosing is straightforward—1000mg (1 gram) daily, six days on, one day off. People use "00" or "000" gelatin capsules, measure with a milligram scale, and cap their own doses. A capsule filling machine lets you prepare a week's worth at once.

Ivermectin: The 1.87% veterinary paste (brands like Durvet, Zimecterin) contains 18.7mg of Ivermectin per gram of paste. The horse syringe is marked in weight increments. Each 250-lb marking delivers roughly 0.5 grams of paste, containing approximately 9.35mg of Ivermectin.

For a 200lb person targeting 1 mg/kg, that's roughly 91 mg of Ivermectin—about one full syringe mark (250lbs worth). Some dispense it onto a piece of food (marshmallow, bread, peanut butter) and swallow without chewing. Others use blunt-tip syringes to fill "000" capsules with the paste, refrigerate them to prevent gelatin softening, and swallow them like pills.

Mebendazole is harder to source outside prescriptions, which is why many DIY implementations use Fenbendazole instead.

Both options should be taken with healthy fats for absorption—avocado, eggs, olive oil.

The Unacceptable Reality

Let me be crystal clear: While direct contact with researchers like Dr. Makis may be possible, and networks like TWC and others provide some access to trained physicians, the broader system remains fundamentally broken.

Life-saving protocols documented in peer-reviewed research should not require choosing between expensive cash-based physician oversight or unsupervised self-experimentation. The average person shouldn't need to hunt down email addresses, navigate obscure physician networks, or resort to veterinary pharmaceuticals to access treatments with better safety profiles than most prescription medications.

Physicians should not face license threats for discussing repurposed drugs. Patients should not have to hide their protocols from oncologists. Researchers with documented results should not operate on the fringes of medicine instead of leading it.

This system is designed to fail you. The regulatory apparatus ensures that affordable, effective treatments remain difficult to access while expensive pharmaceutical interventions get fast-tracked approval.

Until this changes—if it ever changes—prevention becomes paramount.

Prevention: The Only Truly Accessible Protocol

If you've been vaccinated and face elevated turbo cancer risk, you cannot afford to wait for the system to catch up. If you have family history of cancer, standard risk factors, or just want to optimize your odds, prevention is your most powerful tool.

And prevention isn't about taking one magic supplement or following one perfect diet. It's about building terrain where cancer cannot thrive.

This is where functional health practitioners operating outside institutional medicine provide real value. We're not treating disease—we're optimizing the biological systems that prevent disease.

The terrain approach recognizes that cancer represents comprehensive system failure. Fixing that terrain means addressing mitochondrial function, hormonal balance, immune surveillance, inflammatory control, detoxification capacity, circadian biology, and metabolic health simultaneously.

You can't supplement your way out of circadian dysfunction. You can't diet your way past toxic burden. You can't bio-hack around chronic stress and sleep deprivation.

But you CAN measure these systems. You CAN identify where YOUR unique biology is compromised. You CAN systematically strengthen each component.

Functional labs reveal what standard blood work misses. DUTCH Complete hormone testing shows steroid hormone dynamics that affect everything from sleep architecture to immune function to cancer surveillance. Organic acids testing maps mitochondrial efficiency and neurotransmitter production. Food sensitivity panels identify inflammatory triggers standard elimination diets miss. Heavy metal and environmental toxin testing reveals burdens that accumulate silently for decades.

Then you build protocols based on YOUR data, not generic recommendations. Customized nutrition that respects your genetics and current function. Targeted supplementation addressing your specific deficiencies. Light exposure protocols optimized for your latitude and lifestyle. EMF mitigation strategies appropriate to your environment. Stress management approaches that work for YOUR nervous system.

This isn't sexy. It's not a quick fix. But it's how you build anti-fragile health that resists not just cancer but every chronic disease rooted in metabolic dysfunction.

For those already dealing with cancer—whether newly diagnosed or in remission—this terrain-building approach provides the foundation that allows any intervention (conventional or alternative) to work optimally. You cannot kill cancer cells in a body too metabolically compromised to mount an immune response. You cannot detoxify chemotherapy byproducts without functioning detox pathways. You cannot recover from treatment without healthy mitochondria producing cellular energy.

This is my lane as an FDN-P. I'm not treating cancer. I'm not prescribing protocols. I'm helping people verify their biological function with data, identify the upstream dysfunctions, and systematically restore the terrain where health becomes possible.

The system may never give you easy access to repurposed drug protocols. But it can't stop you from optimizing your biology with natural approaches, functional testing, and lifestyle interventions that strengthen every system cancer needs to fail in order to proliferate.

The Binary Choice: Self-Sovereignty or Institutional Dependence

This interview aired several months ago. The information hasn't gone mainstream. The clinical trials haven't been funded. The oncologists are still following rigid protocols while patients die needlessly.

These are "truly safe and effective" protocols—Makis's words—in stark contrast to the marketing slogans applied to mandated interventions. Yet they remain suppressed by design. The weight of that reality is staggering when you consider the lives that could have been saved.

There's no money in curing cancer with cheap, off-patent drugs. There's enormous money in managing cancer with expensive, patented treatments.

The infrastructure for medical tyranny exists. Captured regulatory agencies. Compliant medical boards. Threatened physicians. Bullied patients. Institutional gatekeepers deciding who gets access to which information.

Your defense requires the same strategy that protects your Bitcoin: self-custody, verification, and refusal to trust centralized authorities with your most valuable assets.

You have the information now. What you do with it is your choice.

But understand this: Time is the ultimate non-renewable resource. You can always acquire more Bitcoin. You can't buy back time spent degrading your health. You can't purchase new beta cells after your pancreas fails. You can't restore neurons after neurodegeneration advances.

Your biological stack is either appreciating or depreciating. There is no neutral. Every day of suboptimal function compounds—either toward health or toward dysfunction.

Stack your health like you stack your sats. With proof of work, not proof of authority. With verification, not trust. With sovereignty, not dependence.

The window for easy intervention narrows with each passing year. The cost of correction increases as dysfunction deepens. The time to act is while you still have biological capital to invest.

Don't wait for the establishment to give you permission to optimize your health. They never will. Their incentives don't align with your thriving.

Unplug from their medical matrix the same way you unplugged from their monetary one.

Self-custody your health. Verify your biology. Build your resilience stack now, while you still can.

The rabbit hole is deeper than you think. But the treasure at the bottom—genuine health sovereignty—is worth the descent.

www.sleuthwellness.com

Note: This newsletter is for educational purposes only and is not intended to diagnose, treat, or cure any medical condition. The information about repurposed drug protocols is presented for educational awareness and is not medical advice. As a Functional Diagnostic Nutrition Practitioner (FDN-P), I do not diagnose disease, prescribe medications, or treat medical conditions. My work focuses on natural approaches to optimizing biological function through lifestyle, nutrition, and functional lab interpretation. Any decisions regarding cancer treatment, including the use of repurposed drugs, should be made in consultation with qualified licensed physicians. The sourcing and dosing information provided reflects publicly available data and patient experiences, not recommendations for self-treatment. Always consult with qualified healthcare providers regarding any health concerns, especially when dealing with serious conditions like cancer.